Walter Curran
Radiation Oncology · Atlanta, GANPI 1326060773
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $79,026 of the $83,412 with a category attached, or 94.7%. E.r. Squibb & Sons, L.L.C. accounts for 75.2% of it on its own, with 31 other manufacturers making up the rest. Among radiation oncology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $672.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$63K
- AstraZeneca$9K
- Amgen$6K
- GSK$3K
- Elekta, Inc.$509
- Merck$404
- plus $2K from 26 others
Across 9 payments — averaging $238,484 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$2M
- Lilly USA, LLC$127K
- Amgen$14K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$79,02695%
- Travel & lodging$1,0271%
- Food & beverage$3,3594%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 22 | $62,720 |
| AstraZeneca | 20 | $8,798 |
| Amgen | 2 | $5,831 |
| GSK | 1 | $2,925 |
| Elekta, Inc. | 4 | $509 |
| Merck | 19 | $404 |
| Viewray Technologies Inc | 3 | $336 |
| Genentech USA, Inc. | 8 | $275 |
| Varian Medical Systems, Inc. | 2 | $232 |
| Johnson & Johnson | 3 | $189 |
| Sanofi | 7 | $184 |
| Brainlab, Inc. | 2 | $147 |
| AbbVie | 3 | $127 |
| Boston Scientific | 1 | $110 |
| Daiichi Sankyo Inc. | 4 | $96 |
| Novartis | 4 | $93 |
| Eisai Inc. | 4 | $81 |
| Siemens Medical Solutions USA, Inc. | 1 | $39 |
| Recordati_rare_diseases_inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $27 |
| Novocure Inc. | 1 | $26 |
| Pfizer | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Gilead | 1 | $20 |
| Bayer | 1 | $19 |
| Exelixis Inc. | 1 | $13 |
| Pharmaand GmbH | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$8,197
- ELEKTA MEDICAL LINEAR ACCELERATOR$429
- MRIdian LINAC$311
- RYBREVANT$141
- TrueBeam$128
- SpaceOAR VUE System - 10mL$110
- Eclipse$105
How this compares
$83,412 in reported general payments places this provider in the 95th percentile of 165 radiation oncology providers in Georgia.
Other radiation oncology in Atlanta
- Kristin HigginsAtlanta$230K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
- Ashesh JaniAtlanta$10K
- Frederick SchnellAtlanta$6K
- Mohammad KhanAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.